(Q42540557)

2 November 2017

title

Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin (English)

1 reference

2 November 2017

main subject

liver transplantation

1 reference

1 reference

1 reference

J S Markowitz

1 reference

2 November 2017

P Martin

1 reference

2 November 2017

A J Conrad

1 reference

2 November 2017

J F Markmann

1 reference

2 November 2017

P Seu

1 reference

2 November 2017

H Yersiz

1 reference

2 November 2017

J A Goss

1 reference

2 November 2017

P Schmidt

1 reference

2 November 2017

A Pakrasi

1 reference

2 November 2017

L Artinian

1 reference

2 November 2017

N G Murray

1 reference

2 November 2017

D K Imagawa

1 reference

2 November 2017

C Holt

1 reference

2 November 2017

L I Goldstein

1 reference

2 November 2017

R Stribling

1 reference

2 November 2017

R W Busuttil

1 reference

2 November 2017

language of work or name

English

0 references

publication date

1 August 1998

1 reference

2 November 2017

1 reference

2 November 2017

1 reference

2 November 2017

1 reference

2 November 2017

page(s)

585-589

1 reference

Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications

2 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280241

7 January 2021

Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280241

7 January 2021

Liver transplantation in European patients with the hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280241

7 January 2021

Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280241

7 January 2021

Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280241

7 January 2021

Liver transplantation in HBsAg-positive HBV-DNA--negative cirrhotics: immunoprophylaxis and long-term outcome

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280241

7 January 2021

Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280241

7 January 2021

Liver transplantation for chronic hepatitis B in Asians

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280241

7 January 2021

Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280241

7 January 2021

Effects of lamivudine on replication of hepatitis B virus in HIV-infected men.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280241

7 January 2021

A preliminary trial of lamivudine for chronic hepatitis B infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280241

7 January 2021

Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280241

7 January 2021

Hepatitis and cholestasis in a middle-aged woman

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280241

7 January 2021

Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280241

7 January 2021

Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280241

7 January 2021

Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280241

7 January 2021

The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280241

7 January 2021

Hepatitis B virus surface antigen and polymerase gene variants: Potential virological and clinical significance

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280241

7 January 2021

Corticosteroids stimulate hepatitis B virus DNA, mRNA and protein production in a stable expression system

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280241

7 January 2021

Liver transplantation in HBs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunization

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280241

7 January 2021

Retransplantation in hepatitis B--a multicenter experience

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280241

7 January 2021

Hepatitis B and C coinfections and persistent hepatitis B infections: clinical outcome and liver pathology after transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280241

7 January 2021

Recurrence of hepatitis B and delta hepatitis after orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280241

7 January 2021

Identifiers

DOI

10.1002/HEP.510280241

1 reference

2 November 2017

1 reference